L&P Convinces the PTAB not to Institute Trial against Memory Chip Patent Kevin LaurenceFebruary 2, 2018
L&P Convinces Federal Circuit to Revise Board’s Overbroad Claim Interpretation Press ReleaseKevin LaurenceNovember 6, 2017
L&P Client Vivex Biomedical Settles with MiMedx Group in Patent Dispute Kevin LaurenceOctober 23, 2017
L&P Co-Sponsors the Fourth Annual Corporate IP Strategy Conference (CIPSC) Conferences/SeminarsKevin LaurenceOctober 19, 2017
Trial Instituted Against Novartis’s Patent for Afinitor® Drug Press ReleaseKevin LaurenceSeptember 29, 2017
Kevin Laurence Speaking on Post-Grant Review Options at Kraus & Weisert’s Seminar in Munich, Germany Conferences/SeminarsKevin LaurenceSeptember 19, 2017
L&P Attorneys Teach “Post-Grant Patent Practice” Advanced Course for PRG Conferences/SeminarsKevin LaurenceSeptember 15, 2017
L&P Co-Sponsors the Third Post-Grant Practice Roundtable Discussion at GWU Law School Conferences/SeminarsKevin LaurenceSeptember 8, 2017
Kevin Laurence Participates in Panel at IPO’s Annual Meeting on Post-Grant Proceedings Conferences/SeminarsKevin LaurenceSeptember 1, 2017
L&P's Client Argentum Pharmaceuticals and Eli Lilly Settle Patent Dispute over Cialis® Drug Press ReleaseKevin LaurenceAugust 22, 2017